SCHEMBL23237100

SCHEMBL23237100

c1ccc(-c2ccc(N(c3ccc(-c4ccccc4-c4cccc(-c5cccc6ccccc56)c4)cc3)c3ccc(-c4cccc5c4oc4ccccc45)cc3)cc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.51
GGPS1 O95749 1/20 0.42
PRKDC P78527 5/20 0.39
PTGES2 Q9H7Z7 1/20 0.39
CA12 O43570 2/20 0.39
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
CA9 Q16790 2/20 0.39
MCL1 Q07820 1/20 0.37
ACMSD Q8TDX5 1/20 0.37
PLA2G2A P14555 1/20 0.35
PLA2G4A P47712 1/20 0.35
PRMT5 O14744 1/20 0.35
WDR77 Q9BQA1 1/20 0.35
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
MAPT P10636 2/20 0.34
HPGD P15428 2/20 0.34
HSD17B10 Q99714 2/20 0.34
ENPP3 O14638 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10110164 0.98 ALOX5 (0.51) ALOX5GGPS1PRKDCPTGES2CA12
SCHEMBL18655586 0.98 ALOX5 (0.51) ALOX5GGPS1PRKDCPTGES2CA12
SCHEMBL17705897 0.98 ALOX5 (0.51) ALOX5GGPS1PRKDCPTGES2CA12
SCHEMBL23239554 0.98 ALOX5 (0.51) ALOX5GGPS1PRKDCPTGES2CA12
SCHEMBL23237094 0.98 ALOX5 (0.51) ALOX5GGPS1PRKDCPTGES2CA12
SCHEMBL23239131 0.98 ALOX5 (0.51) ALOX5GGPS1PRKDCPTGES2CA12
SCHEMBL23237099 0.98 ALOX5 (0.51) ALOX5GGPS1PRKDCPTGES2CA12
SCHEMBL23239189 0.98 ALOX5 (0.51) ALOX5GGPS1PRKDCPTGES2CA12
SCHEMBL23239493 0.96 ALOX5 (0.50) ALOX5GGPS1PRKDCPTGES2CA12
SCHEMBL23238630 0.96 ALOX5 (0.50) ALOX5GGPS1PRKDCPTGES2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230227397-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-07-20 US disclosed
US-20230227397-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-07-20 US disclosed
WO-2021070964-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE 出光興産株式会社 2021-04-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227397-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE LEF1, PIEZO1, ELAVL1 ALOX5 1352/4885GGPS1 1940/4885PRKDC 4563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.